Aptar Expands Footprint with New Pharmaceutical Plant in India

AptarGroup has announced a new pharmaceutical plant in Taloja, India, expanding its presence in the region to meet growing industry demands. This facility will bolster their production capabilities and support future growth opportunities in India's pharmaceutical sector.

AptarGroup, a global leader in drug dosing and dispensing technologies, has unveiled plans to build a new pharmaceutical plant in Taloja, India. The facility aims to strengthen the company's position in India by enhancing production capacity for its innovative inhaler valves and spray devices.

President of Aptar Pharma India, Sanjay Kapote, emphasized the plant's role in meeting rising demand and explored the potential for acquisitions in the local pharmaceutical space. The new plant, covering 4400 m2, will complement Aptar's existing Mumbai facility, augmenting their market presence through strategic growth and partnerships.

This expansion reflects Aptar's commitment to the industry's promising future, incorporating state-of-the-art technology to serve diverse markets, including pharmaceuticals, beauty, and personal care, globally.

(With inputs from agencies.)